documents: FDA-2012-N-0002-0041
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2012-N-0002-0041 | FDA | FDA-2012-N-0002 | Freedom of Information Summary NADA 200-534 Melengestrol acetate plus monensin USP plus tylosin phosphate | Supporting & Related Material | Freedom of Information Summary | 2013-01-04T05:00:00Z | 2013 | 1 | 2013-01-04T17:21:54Z | 0 | 0 | 09000064811a7caf |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref